OBEZİTE VE GENETİK YATKINLIK

Authors

Fulya Yükçü
https://orcid.org/0000-0003-3468-2655

Synopsis

This section examines the epidemiology, genetic basis, and methodological approaches used to identify obesity, which is defined by the World Health Organization as excessive fat accumulation. While the prevalence of obesity is rapidly increasing globally, genetic susceptibility is reported to contribute 40-70% alongside environmental factors. Genetically, obesity is classified into syndromic obesity accompanied by cognitive and organ abnormalities, monogenic obesity resulting from defects in the leptin-melanocortin pathway (most commonly MC4R deficiency), and polygenic obesity arising from the interaction of environmental factors with multiple gene variants such as the FTO gene. Three primary methodological strategies are utilized to detect obesity genes: the candidate gene approach, genome-wide linkage scans, and genome-wide association studies (GWAS). While candidate gene studies highlight genes such as BDNF, MC4R, PPARG, and GPR120, GWAS studies have enabled the discovery of novel loci associated with obesity and body mass index (BMI). Although only a small portion of obesity's heritability has been explained to date, elucidating these molecular mechanisms will facilitate disease prevention and the development of novel therapeutic strategies.

References

World Health Organization Obesity and Overweight Fact Sheets. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. Erişim. 23.03.2021.

Türkiye Endokrinoloji Ve Metabolizma Derneği Obezite Tanı ve Tedavi Kılavuzu 2019. ISBN 978-605-4011-31-5

Kleinendorst L, Massink MPG, Cooiman MI, Savas M, van der Baan-Slootweg OH. Genetic obesity: next-generation sequencing results of patients with obesity. J Med Genet. 2018 Sep;55(9):578-586. doi: 10.1136/jmedgenet-2018-105315. Epub 2018 Jul 3. PMID: 29970488.

González-Muniesa, P., Mártinez-González, MA., Hu, F. et al. Obesity. Nat Rev Dis Primers 3, 17034 (2017). https://doi.org/10.1038/nrdp.2017.34

Larder R, Lim CT, Coll AP. Genetic aspects of human obesity. Handb Clin Neurol. 2014;124:93-106. doi: 10.1016/B978-0-444-59602-4.00006-X. PMID: 25248581.

Sicat J. (2018). Obesity and Genetics: Nature and Nurture. Obesity Medicine Association. https://obesitymedicine.org/obesity-and-genetics/

Lakka H. M, Bouchard C. (2007). Etiology of Obesity. Surgical Management of Obesity (18-28).

Butler MG. Single Gene and Syndromic Causes of Obesity: Illustrative Examples. Prog Mol Biol Transl Sci. 2016;140:1-45.

Zhang YP, Zhang YY, Duan DD. From Genome-Wide Association Study to Phenome-Wide Association Study: New Paradigms in Obesity Research. Prog Mol Biol Transl Sci. 2016;140:185-231.

Kaur Y, de Souza RJ, Gibson WT, Meyre D. A systematic review of genetic syndromes with obesity. Obes Rev. 2017 Jun;18(6):603-634.

Waalen J. The genetics of human obesity. Transl Res. 2014 Oct;164(4):293-301. doi: 10.1016/j.trsl.2014.05.010.

Pigeyre M, Yazdi F.T, Kaur Y, Meyre D. Recent progress in genetics, epigenetics and metagenomics unveils the pathophysiology of human obesity Clin Sci (Lond), 130 (2016), pp. 943-986.

Inanc M. (2015). Obezitede önemli bir risk faktörü: Genetik mekanizma An important risk factor for obesity: Genetic mechanism. İzmir Üniversitesi Tıp Dergisi. 2015. 37-43.

Vos, N, Oussaada, S.M, Cooiman, M.I. et al. Bariatric Surgery for Monogenic Non-syndromic and Syndromic Obesity Disorders. Curr Diab Rep 20, 44 (2020).

Heianza Y, Qi L. (2019). Genetics of Central Obesity and Body Fat. Nutrition in the Prevention and Treatment of Abdominal Obesity (Second Edition). (153-174). Academic Press.

Lubrano-Berthelier C, Durand E, Dubern B, et al. Intracellular retention is a common characteristic of childhood obesity-associated MC4R mutations. Hum Mol Genet. 2003;12(2):145–153.

Rankinen T, Zuberi A, Chagnon YC, et al. The human obesity gene map: the 2005 update. Obesity (Silver Spring, Md). 2006;14(4):529–644.

Rohde K, Keller M, la Cour Poulsen L, Blüher M, Kovacs P, Böttcher Y. Genetics and epigenetics in obesity. Metabolism. 2019 Mar;92:37-50. doi: 10.1016/j.metabol.2018.10.007.

Alonso, Rodrigo & Farías, María & Álvarez, Verónica & Cuevas, Ada. (2016). The Genetics of Obesity. 10.1016/B978-0-12-799961-6.00007-X.

Dina C, Meyre D, Gallina S et al. Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet 2007; 39(6): 724–726.

Chagnon YC, Rankinen T, Snyder EE, et al: The human obesity gene map: the 2002 update. Obes Res 2003;11:313-367.

Razquin C, Marti A, Martinez JA (2011) Evidences on three relevant obesogenes: MC4R, FTO and PPARγ. Approaches for personalized nutrition. Mol Nutr Food Res 55:136–149.

Milagro F, & Moreno A.M, Martinez A. (2020). Nutrients, Obesity and Gene Expression. Principles of Nutrigenetics and Nutrigenomics (pp.431-440). 10.1016/B978-0-12-804572-5.00058-6.

Apalasamy Y.D, Mohamed Z. (2015) Obesity and genomics: role of technology in unraveling the complex genetic architecture of obesity. Hum. Genet. 134, 361–374

Tam V, Turcotte M, Meyre D. Established and emerging strategies to crack the genetic code of obesity. Obes Rev. 2019 Feb;20(2):212-240. doi: 10.1111/obr.12770.

Li A, Meyre D. Challenges in reproducibility of genetic associ-ation studies: lessons learned from the obesity field. Int J Obes(Lond) 2013; 37(4): 559–567.

Vimaleswaran KS, Tachmazidou I, Zhao JH, Hirschhorn JN,Dudbridge F, Loos RJ. Candidate genes for obesity-susceptibilityshow enriched association within a large genome-wide associationstudy for BMI. Hum Mol Genet 2012; 21(20): 4537–4542

Xu B, Goulding EH, Zang K et al. Brain-derived neurotrophicfactor regulates energy balance downstream of melanocortin-4 re-ceptor. Nat Neurosci 2003; 6(7): 736–742.

Gray J, Yeo GS, Cox JJ et al. Hyperphagia, severe obesity, im-paired cognitive function, and hyperactivity associated withfunctional loss of one copy of the brain-derived neurotrophic factor(BDNF) gene. Diabetes 2006; 55(12): 3366–3371.

Shugart YY, Chen L, Day IN et al. Two British women studiesreplicated the association between the Val66Met polymorphism inthe brain-derived neurotrophic factor (BDNF) and BMI. Eur JHum Genet 2009; 17(8): 1050–1055.

Gunstad J, Schofield P, Paul RH et al. BDNF Val66Met poly-morphism is associated with body mass index in healthy adults.Neuropsychobiology 2006; 53(3): 153–156.

Speliotes EK, Willer CJ, Berndt SI et al . Association analysesof 249,796 individuals reveal 18 new loci associated with bodymass index. Nat Genet 2010; 42(11): 937–948

Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T,O’Rahilly S. Clinical spectrum of obesity and mutations in themelanocortin 4 receptor gene. N Engl J Med 2003; 348(12):1085–1095.

Huszar D, Lynch CA, Fairchild-Huntress V et al. Targeteddisruption of the melanocortin-4 receptor results in obesity in mice.Cell 1997; 88(1): 131–141.

Vaisse C, Clement K, Guy-Grand B, Froguel P. A frameshiftmutation in human MC4R is associated with a dominant form ofobesity. Nat Genet 1998; 20(2): 113–114.

Xiang Z, Litherland SA, Sorensen NB et al. Pharmacologicalcharacterization of 40 human melanocortin-4 receptor polymor-phisms with the endogenous proopiomelanocortin-derivedagonists and the agouti-related protein (AGRP) antagonist. Bio-chemistry 2006; 45(23): 7277–7288.

Stutzmann F, Vatin V, Cauchi S et al. Non-synonymous poly-morphisms in melanocortin-4 receptor protect against obesity: thetwo facets of a Janus obesity gene. Hum Mol Genet 2007; 16(15):1837–1844.

Krief S, Lonnqvist F, Raimbault S et al. Tissue distribution ofbeta 3-adrenergic receptor mRNA in man. J Clin Invest 1993;91(1): 344–349.

Enocksson S, Shimizu M, Lonnqvist F, Nordenstrom J, ArnerP. Demonstration of an in vivo functional beta 3-adrenoceptor inman. J Clin Invest 1995; 95(5): 2239–2245.

Lonnqvist F, Thome A, Nilsell K, Hoffstedt J, Arner P. Apathogenic role of visceral fat beta 3-adrenoceptors in obesity. J Clin Invest 1995; 95(3): 1109–1116.

Cho MC, Lee K, Paik SG, Yoon DY. Peroxisome Proliferators-Activated Receptor (PPAR) Modulators and Metabolic Disorders. PPAR Res. 2008;2008:679137. doi:10.1155/2008/679137.

Gerstein HC, Yusuf S, Bosch J et al. Effect of rosiglitazone onthe frequency of diabetes in patients with impaired glucose toler-ance or impaired fasting glucose: a randomised controlled trial.Lancet 2006; 368(9541): 1096–1105.

Galbete C, Toledo E, Martinez-Gonzalez MA, Martinez JA,Guillen-Grima F, Marti A. Pro12Ala variant of the PPARG2 gene increases body mass index: an updated meta-analysis encompassing49,092 subjects. Obesity (Silver Spring) 2013; 21(7): 1486–1495.

Turcot V, Lu Y, Highland HM et al. Protein-altering variants associated with body mass index implicate pathways that controlenergy intake and expenditure in obesity. Nat Genet 2018; 50(1):26–41.

Hirasawa A, Tsumaya K, Awaji T et al. Free fatty acids regu-late gut incretin glucagon-like peptide-1 secretion through GPR120.Nat Med 2005; 11(1): 90–94.

Oh DY, Talukdar S, Bae EJ et al. GPR120 is an omega-3 fattyacid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010; 142(5): 687–698.

Ichimura A, Hirasawa A, Poulain-Godefroy O et al. Dysfunc-tion of lipid sensor GPR120 leads to obesity in both mouse andhuman. Nature 2012; 483(7389): 350–354.

Corella D, Arregui M, Coltell O, et al. Association of the LCT-13910C>T polymorphism with obesity and its modulation by dairy products in a Mediterranean popu¬lation. Obesity (Silver Spring). 2011;19(8):1707–1714.

Pietiläinen KH, Kaprio J, Rissanen A, Winter T, Rimpelä A, Viken RJ, Rose RJ: Distribution and heritability of BMI in Finnish adolescents aged 16y and 17y: a study of 4884 twins and 2509 singletons. Int J Obes Relat Metab Disord 1999;23:107–115.

Fabsitz RR, Carmelli D, Hewitt JK: Evidence for independent genetic influences on obesity in middle age. Int J Obes Relat Metab Disord 1992;16: 657–666.

Saar K, Geller F, Rüschendorf F, et al. Genome scan for childhood and adolescent obesity in German families. Pediatrics 2003;111:321–327.

Meyre D, Lecoeur C, Delplanque J, et al. A genome-wide scan for childhood obesity-associated traits in French families shows significant Linkage on chromosome 6q22.31-q23.2. Diabetes 2004;53: 803–811.

Boutin P, Dina C, Vasseur F. et al. GAD2 on chromosome 10p12 is a candidate gene for human obesity. PLoS Biol. 2003;1:e68.

Suviolahti E, Oksanen LJ, Ohman M, et al. The SLC6A 14 gene shows evidence of association with obesity. J Clin Invest. 2003;112:1762–1772.

Meyre D, Bouatia-Naji N, Tounian A, et al. Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes. Nat Genet. 2005;37:863–867.

Saunders CL, Chiodini BD, Sham P, et al. Meta-analysis of genome-wide linkage studies in BMI and obesity. Obesity (Silver Spring) 2007;15:2263–2275.

Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science. 1996;273:1516–1517.

Visscher PM, Brown MA, McCarthy MI, Yang J. Five years of GWAS discovery. Am J Hum Genet 2012; 90(1): 7–24.

Visscher PM, Wray NR, Zhang Q et al. 10 years of GWAS discovery: biology, function, and translation. Am J Hum Genet2017; 101(1): 5–22.

Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007;316(5826):889–894.

Hinney A, Nguyen TT, Scherag A, et al. Genome wide asso-ciation (GWA) study for early onset extreme obesity sup¬ports the role of fat mass and obesity associated gene (FTO) variants. Kronenberg F, ed. PLoS One. 2007;2(12):e1361.

Published

May 11, 2021

License

License